AM PHARMA

am-pharma-logo

AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derived peptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.

#SimilarOrganizations #People #Financial #Event #Website #More

AM PHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical

Founded:
2000-01-01

Address:
Bunnik, Utrecht, The Netherlands

Country:
The Netherlands

Website Url:
http://www.am-pharma.com

Total Employee:
11+

Status:
Active

Contact:
+ 31 (0)30 228 92 22

Total Funding:
207.54 M EUR

Technology used in webpage:
Google Maps ReCAPTCHA Person Schema Gravatar Profiles Gravity Forms Akismet Akismet Non Hosted Dutch Server Location


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

arphio-logo

Arphio

Arphio is an orphan pharmaceutical company founded on the mission to improve patient access to vital treatments for rare diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

sidanis-logo

SIDANIS

SIDANIS is a biopharmaceutical company specialized in developing drugs to prevent and treat infectious diseases in human & animal health.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

treamid-therapeutics-logo

Treamid Therapeutics

Treamid Therapeutics is a pharmaceutical company that new chemical entities for inflammatory respiratory and endocrine diseases.


Current Advisors List

laia-crespo_image

Laia Crespo Board Observer @ AM Pharma
Board_observer
2011-01-01

bart-bergstein_image

Bart Bergstein Board Member @ AM Pharma
Board_member

joel-jean-mairet_image

Joel Jean Mairet Board Director @ AM Pharma
Board_member
2011-01-01

raphaël-wisniewski_image

Raphaël Wisniewski Board of Directors @ AM Pharma
Board_member

geert-jan-mulder_image

Geert Jan Mulder Board of Directors @ AM Pharma
Board_member

felice-verduyn_image

Felice Verduyn Board of Directors @ AM Pharma
Board_member

martijn-kleijwegt_image

Martijn Kleijwegt Board of Directors @ AM Pharma
Board_member

remi-droller_image

Remi Droller Board of Directors @ AM Pharma
Board_member

Current Employees Featured

erik-berg_image

Erik Berg
Erik Berg Chief Executive Officer @ AM Pharma
Chief Executive Officer
2011-06-01

not_available_image

Peter Verwaijen
Peter Verwaijen Vice-President of Finance @ AM Pharma
Vice-President of Finance
2011-01-01

jacques-arend_image

Jacques Arend
Jacques Arend Chief Medical Officer and Vice President of Clinical @ AM Pharma
Chief Medical Officer and Vice President of Clinical
2008-03-01

tim-knotnerus_image

Tim Knotnerus
Tim Knotnerus Vice-President of Corporate Development @ AM Pharma
Vice-President of Corporate Development
2012-06-01

Founder


martin-hessing_image

Martin Hessing

Investors List

eurazeo-com_image

Eurazeo

Eurazeo investment in Venture Round - AM Pharma

cowen-healthcare-investments_image

Cowen Healthcare Investments

Cowen Healthcare Investments investment in Venture Round - AM Pharma

idinvest-partners_image

Idinvest Partners

Idinvest Partners investment in Venture Round - AM Pharma

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Venture Round - AM Pharma

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Venture Round - AM Pharma

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Venture Round - AM Pharma

ysios-capital_image

Ysios Capital

Ysios Capital investment in Venture Round - AM Pharma

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Debt Financing - AM Pharma

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Venture Round - AM Pharma

kurma-life-science-partners_image

Kurma Partners

Kurma Partners investment in Venture Round - AM Pharma

Official Site Inspections

http://www.am-pharma.com Semrush global rank: 7 M Semrush visits lastest month: 940

  • Host name: ayni.savviihq.com
  • IP address: 62.221.215.181
  • Location: Netherlands
  • Latitude: 52.3824
  • Longitude: 4.8995
  • Timezone: Europe/Amsterdam

Loading ...

More informations about "AM Pharma"

AM Pharma - Crunchbase Company Profile & Funding

AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It …See details»

AM-Pharma Org Chart + Executive Team - The Official Board

AM-Pharma Org Chart www.am-pharma.com. has 10 executives +31 30 228 92 2; Add an executive. AM-Pharma News . Anything missing? We search for you. Print or download . CEO. …See details»

AM-Pharma 2025 Company Profile: Valuation, Funding …

AM-Pharma General Information Description. Operator of a medical research firm intended to develop alkaline phosphatase biologic therapies to treat acute …See details»

AM Pharma

Sep 10, 2015 AM‐Pharma is a biopharmaceutical company focused on the preclinical and clinical development of recAP (recombinant Human Alkaline Phosphatase) as a treatment of …See details»

AM Pharma Company Profile - Office Locations, Competitors

AM Pharma has 5 employees across 2 locations and $210.28 m in total funding,. See insights on AM Pharma including office locations, competitors, revenue, financials, executives, …See details»

AM-Pharma - Overview, News & Similar companies | ZoomInfo.com

Oct 11, 2023 AM-Pharma Provides Business Update and Outcome of Pre-planned Interim Futility Analysis of Phase 3 REVIVAL Study UTRECHT, The Netherlands--(BUSINESS WIRE) …See details»

AM-Pharma - Profile - dhbriefs.com

AM-Pharma is a clinical-stage biopharmaceutical company developing a treatment for sepsis-associated acute kidney injury (SA-AKI) - recombinant human alkaline phosphatase …See details»

AM-Pharma - F6S

AM-Pharma - AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions. Our focus is on cardiac surgery-associated renal damage (CSA …See details»

AM PHARMA Company Profile | Thane, Maharashtra, India

Find company research, competitor information, contact details & financial data for AM PHARMA of Thane, Maharashtra. Get the latest business insights from Dun & Bradstreet.See details»

AM-Pharma - BCF Career

AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use. AM-Pharma’s purpose is to save the lives of patients confronted with kidney …See details»

AM-Pharma BV - Drug pipelines, Patents, Clinical trials - Synapse

Explore AM-Pharma BV with its drug pipeline, therapeutic area, technology platform, 17 clinical trials, 20 news, and 1 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»

AM-Pharma - Gilde Healthcare

AM-Pharma is a Dutch biopharmaceutical company developing a biotherapeutic for the treatment of Sepsis Associated Acute Kidney Injury (SA-AKI). The company successfully completed a …See details»

☑️AM-Pharma — Consulting Organization from the Netherlands …

AM-Pharma — Consulting Organization from the Netherlands with 11-50 employees, it`s involved in Health, Laboratory & Measurement sectors. Our website uses cookies to enable essential …See details»

About Us - AM Pharma

Martijn Kleijwegt, is a Managing Partner and Founder at LSP and a pioneer in the European life sciences arena. He was instrumental in the successes of Prosensa (NL, IPO in 2013, sold to …See details»

AM-Pharma: Revenue, Worth, Valuation & Competitors 2025

About AM-Pharma. AM-Pharma is a Biotech related company founded in 2002 with 38 employees an estimated revenue of $2.9M, and. It has 10 competitors including Dermavant Sciences, …See details»

AM-Pharma | Biotech Careers

AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects …See details»

AM Pharma - Funding, Financials, Valuation & Investors

AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases. New. Resources. Advanced Search. Start Free Trial . …See details»

Investors - AM Pharma

AM-Pharma is backed by a strong syndicate of international investors, including venture capital funds and corporate venture funds. To date, the company has raised over €190 million in …See details»

Yale Law Journal - Does Pharma Need Patents?

Introduction. Does pharma need patents? The consensus view among scholars is a resounding “yes.” The pharmaceutical industry is widely agreed to be the sector most in need of strong …See details»

Silo Pharma, Inc. Announces Agreement with Frontage ... - Nasdaq

2 days ago Silo Pharma announces agreement for FDA-required safety study of SPC-15, an intranasal PTSD treatment, with Frontage Laboratories. ... May 14, 2025 — 08:51 am EDT.See details»

linkstock.net © 2022. All rights reserved